Companies / ALC

ALCIDION GROUP LIMITED

ASX:ALCHealth Care Equipment & Services
1.34B shares on issueASX (delayed) · as of 28 July 2026$0.086price · delayed$119.6Mmarket cap · indicative
A
Dilution grade

No major dilution pressure signals in current disclosures

Cash runway13.1 quarters of funding
Share-count growth (24m)0.0%
Raise cadence (24m)0 cash raises
Options & rights overhang2.3% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

ALCIDION GROUP LIMITED's ordinary share count stood at 1.34B shares as of May 2026, unchanged (0.0%) since September 2024. There were no capital raises in the 24-month window. Options and rights could convert into 31M new shares, equal to 2.3% of the current share count, with the nearest expiry in October 2026 and 0% in the money. At the June 2026 quarter the company reported A$24.2M in cash, representing 13.1 quarters of cover at its reported spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
2.3%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
13.1 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 1.34B per ASX (delayed) (28 July 2026).
1.34BDec 24Sept 25July 26

Cash runway

—
Cover not computed for the latest quarter.
$24.2M available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
28 May 20262A · quoted issueALC : ORDINARY FULLY PAID1.34BAppendix 2A
25 Nov 20253G · unquotedORDINARY FULLY PAID1.34BAppendix 3G
30 Oct 20253H · cancellationALC : ORDINARY FULLY PAID1.34BAppendix 3H
11 Aug 20253H · cancellationALC : ORDINARY FULLY PAID1.34BAppendix 3H
3 June 20253H · cancellationALC : ORDINARY FULLY PAID1.34BAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

2.3%
Total overhang · of current shares
0.0%
In the money · at current price
31.0M
Potential new shares
Oct 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
4 Mar 2025Katrina Elizabeth Doyle (aka Kate Quirke)Sell———3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

22 July 2026$PQ4 FY26 Quarterly Activities Report and Appendix 4C
16 July 2026Alcidion Q4 FY26 Results and Investor Webcast Notification
28 June 2026Investor Roadshow Presentation
28 June 2026$PReconfirming FY26 Guidance and Acquisition Completion
28 May 2026Cleansing Notice
28 May 2026Application for quotation of securities - ALC
28 May 2026Proposed issue of securities - ALC
24 May 2026$PALC signs 7-year contract with UHSussex for EPR platform
17 May 2026$PAcquisition of the Kyra flow products from Telstra Health
28 Apr 2026$PQ3 FY26 Quarterly Activities Report and Appendix 4C
22 Apr 2026Alcidion Q3 FY26 Results and Investor Webcast Notification
25 Feb 2026$PH1 FY26 Results Presentation
25 Feb 2026$PH1 FY26 Results Release
25 Feb 2026$PH1 FY26 Appendix 4D and Half Year Report
18 Feb 2026Alcidion H1 FY26 Results and Investor Webcast Notification
18 Feb 2026$PDual AU and UK Medical Device Registration for AI Capability
22 Jan 2026Change in substantial holding
19 Jan 2026Change in substantial holding
14 Jan 2026$PQ2 FY26 Quarterly Activities Report and Appendix 4C
7 Jan 2026Alcidion Q2 FY26 Results and Investor Webcast Notification

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.